UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sympathetic activation in heart failure

European heart journal supplements, 2022-08, Vol.24 (Supplement_E), p.E4-E11

2022

Volltextzugriff (PDF)

Sustainable and Energy-Efficient Industrial Systems: Modelling the Environmental Impact of Logistics Facilities

Industrial Engineering and Applications - Europe, 2024, Vol.507, p.146-157

2024

Volltextzugriff (PDF)

Cryoballoon ablation for atrial fibrillation guided by real-time three-dimensional transoesophageal echocardiography: a feasibility study

Europace (London, England), 2013-07, Vol.15 (7), p.944-950

2013

Volltextzugriff (PDF)

8B.02: EFFECTS OF LONG-TERM BAROREFLEX ACTIVATION IN CONGESTIVE HEART FAILURE

Journal of hypertension, 2015-06, Vol.33 Suppl 1 - ESH 2015 Abstract Book (Supplement 1), p.e107-e107

2015

Volltextzugriff (PDF)

P471 CLINICAL AND THERAPEUTIC CHARACTERISTICS OF PATIENTS WITH HEART FAILURE IN THERAPY WITH SGLT2I RELATED TO THE HEART FAILURE OUTPATIENT

European heart journal supplements, 2023-05, Vol.25 (Supplement_D), p.D228-D228

2023

Volltextzugriff (PDF)

Heart Rhythm Considerations in Heart Transplant Candidates and Considerations for Ventricular Assist Devices: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates—2006

The Journal of heart and lung transplantation, 2006-09, Vol.25 (9), p.1043-1056

2006

Volltextzugriff (PDF)

Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial

The Lancet (British edition), 2020-12, Vol.396 (10266), p.1895-1904

2020

Volltextzugriff (PDF)

P331 ANALYSIS OF THE CLINICAL AND THERAPEUTIC CHARACTERISTICS OF PATIENTS ADMITTED TO THE HEART FAILURE CLINIC IN THE PERIOD APRIL–SEPTEMBER 2022. ORGANIZED BY THE ANMCO AREA CARDIO RENO METABOLICA

European heart journal supplements, 2023-05, Vol.25 (Supplement_D), p.D174-D174

2023

Volltextzugriff (PDF)

Treatment of chronic heart failure with β adrenergic blockade beyond controlled clinical trials: the BRING-UP experience

British heart journal, 2003-03, Vol.89 (3), p.299-305

2003

Volltextzugriff (PDF)

P473 SURVEY ON THE USE OF SGLT2I THERAPY: CLINICAL AND THERAPEUTIC CHARACTERISTICS OF PATIENTS WITH HEART FAILURE IN A GROUP OF CENTERS IN PUGLIA, MOLISE AND ABRUZZO. ANMCO CARDIO RENO METABOLIC AREA

European heart journal supplements, 2023-05, Vol.25 (Supplement_D), p.D229-D229

2023

Volltextzugriff (PDF)

Rationale and Process: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates—2006

The Journal of heart and lung transplantation, 2006-09, Vol.25 (9), p.1001-1002

2006

Volltextzugriff (PDF)

A single administration of human umbilical cord blood T cells produces long-lasting effects in the aging hippocampus

AGE, 2013-12, Vol.35 (6), p.2071-2087

2013

Volltextzugriff (PDF)

P469 UP TO 12 MONTH TRENDS IN CLINICAL AND BIOCHEMICAL PARAMETERS AFTER SGLT2I THERAPY IN PATIENTS AFFECTED BY HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION

European heart journal supplements, 2023-05, Vol.25 (Supplement_D), p.D227-D227

2023

Volltextzugriff (PDF)

Resting echocardiography and quantitative dipyridamole technetium-99m sestamibi tomography in the identification of cardiac allograft vasculopathy and the prediction of long-term prognosis after heart transplantation

European heart journal, 2001-06, Vol.22 (11), p.964-971

2001

Volltextzugriff (PDF)

P468 CLINICAL CHARACTERISTICS OF PATIENTS AFFECTED BY HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION AND UNDERGOING SGLT2I THERAPY

European heart journal supplements, 2023-05, Vol.25 (Supplement_D), p.D227-D227

2023

Volltextzugriff (PDF)

[BP.10.04] NORMALIZATION OF SYMPATHETIC NERVE TRAFFIC IN THE LONG TERM FOLLOW-UP AFTER BAROREFLEX ACTIVATION THERAPY IN HEART FAILURE PATIENTS: FINAL STUDY REPORT

Journal of hypertension, 2017-09, Vol.35 (Supplement 2), p.e346

2017

Volltextzugriff (PDF)

P2592Combining home monitoring temporal trends and baseline patient risk profile for predicting impending heart failure hospitalizations. Results from the SELENE HF (BIO.Detect HF IV) study

European heart journal, 2019-10, Vol.40 (Supplement_1)

2019

Volltextzugriff (PDF)

The European experience of Novacor left ventricular assist (LVAS) therapy as a bridge to transplant: a retrospective multi-centre study

European journal of cardio-thoracic surgery, 1999-06, Vol.15 (6), p.835-841

1999

Volltextzugriff (PDF)

Baroflex Activation Therapy for Refractory Congestive Heart Failure: Anesthetic Implications

Journal of cardiothoracic and vascular anesthesia, 2017-06, Vol.31 (3), p.1103-1108

2017

Volltextzugriff (PDF)

Prognostic indices in heart transplant candidates after the first hospitalization triggered by the need for intravenous pharmacologic circulatory support

The Journal of heart and lung transplantation, 1999-07, Vol.18 (7), p.654-663

1999

Volltextzugriff (PDF)

Prognostic value of pulmonary hypertension in patients with chronic interstitial lung disease referred for lung or heart-lung transplantation

The Journal of heart and lung transplantation, 1997-04, Vol.16 (4), p.460-463

1997

Volltextzugriff (PDF)

Restrictive criteria for heart transplantation candidacy maximize survival of patients with advanced heart failure

The Journal of heart and lung transplantation, 1997-02, Vol.16 (2), p.160-168

1997

Volltextzugriff (PDF)

Renal function and mortality in patients with chronic heart failure treated with resynchronization therapy

European heart journal, 2013-08, Vol.34 (suppl 1), p.P3157-P3157

2013

Volltextzugriff (PDF)

1 – 25 von 216

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(152)
Mit Volltextzugriff
(141)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sympathetic activation in heart failure

Sustainable and Energy-Efficient Industrial Systems: Modelling the Environmental Impact of Logistics Facilities

Cryoballoon ablation for atrial fibrillation guided by real-time three-dimensional transoesophageal echocardiography: a feasibility study

8B.02: EFFECTS OF LONG-TERM BAROREFLEX ACTIVATION IN CONGESTIVE HEART FAILURE

P471 CLINICAL AND THERAPEUTIC CHARACTERISTICS OF PATIENTS WITH HEART FAILURE IN THERAPY WITH SGLT2I RELATED TO THE HEART FAILURE OUTPATIENT

Heart Rhythm Considerations in Heart Transplant Candidates and Considerations for Ventricular Assist Devices: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates—2006

Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial

P331 ANALYSIS OF THE CLINICAL AND THERAPEUTIC CHARACTERISTICS OF PATIENTS ADMITTED TO THE HEART FAILURE CLINIC IN THE PERIOD APRIL–SEPTEMBER 2022. ORGANIZED BY THE ANMCO AREA CARDIO RENO METABOLICA

Treatment of chronic heart failure with β adrenergic blockade beyond controlled clinical trials: the BRING-UP experience

P473 SURVEY ON THE USE OF SGLT2I THERAPY: CLINICAL AND THERAPEUTIC CHARACTERISTICS OF PATIENTS WITH HEART FAILURE IN A GROUP OF CENTERS IN PUGLIA, MOLISE AND ABRUZZO. ANMCO CARDIO RENO METABOLIC AREA

Rationale and Process: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates—2006

A single administration of human umbilical cord blood T cells produces long-lasting effects in the aging hippocampus

Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion) study

P469 UP TO 12 MONTH TRENDS IN CLINICAL AND BIOCHEMICAL PARAMETERS AFTER SGLT2I THERAPY IN PATIENTS AFFECTED BY HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION

Sympathetic Response and Outcomes Following Renal Denervation in Patients with Chronic Heart Failure: 12-Month Outcomes From the SYMPLICITY HF Feasibility Study

Resting echocardiography and quantitative dipyridamole technetium-99m sestamibi tomography in the identification of cardiac allograft vasculopathy and the prediction of long-term prognosis after heart transplantation

P468 CLINICAL CHARACTERISTICS OF PATIENTS AFFECTED BY HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION AND UNDERGOING SGLT2I THERAPY

[BP.10.04] NORMALIZATION OF SYMPATHETIC NERVE TRAFFIC IN THE LONG TERM FOLLOW-UP AFTER BAROREFLEX ACTIVATION THERAPY IN HEART FAILURE PATIENTS: FINAL STUDY REPORT

P2592Combining home monitoring temporal trends and baseline patient risk profile for predicting impending heart failure hospitalizations. Results from the SELENE HF (BIO.Detect HF IV) study

The European experience of Novacor left ventricular assist (LVAS) therapy as a bridge to transplant: a retrospective multi-centre study

Baroflex Activation Therapy for Refractory Congestive Heart Failure: Anesthetic Implications

Prognostic indices in heart transplant candidates after the first hospitalization triggered by the need for intravenous pharmacologic circulatory support

Prognostic value of pulmonary hypertension in patients with chronic interstitial lung disease referred for lung or heart-lung transplantation

Restrictive criteria for heart transplantation candidacy maximize survival of patients with advanced heart failure

Renal function and mortality in patients with chronic heart failure treated with resynchronization therapy

Suchergebnisse filtern